OMDA financial statements
The full income statement, balance sheet, and cash-flow statement for Omada Health Inc. (OMDA), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
| Line item | Trend | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | |
| Revenue | 260M+53.2% | 170M+38.3% | 123M | |
| 171M+66.2% | 103M+47.0% | 70.0M | ||
| Cost of revenue | 89.3M+33.4% | 66.9M+26.7% | 52.8M | |
| 183M+24.8% | 147M+7.8% | 136M | ||
| Research & development | 40.7M+13.3% | 35.9M+6.5% | 33.7M | |
| Selling, general & administrative | 52.2M+22.6% | 42.6M+18.3% | 36.0M | |
| General & administrative | 52.2M+22.6% | 42.6M+18.3% | 36.0M | |
| Selling & marketing | 90.0M+32.3% | 68.1M+2.7% | 66.2M | |
| Amortization of intangibles | 1.90M-5.0% | 2.00M+0.0% | 2.00M | |
| Provision for credit losses | 1.19M-32.4% | 1.76M+289.4% | 452K | |
| Operating income | -12.0M+72.6% | -43.7M+33.9% | -66.0M | |
| Interest expense | 2.53M-43.8% | 4.51M-4.2% | 4.71M | |
| Interest & investment income | 5.30M+559.0% | 805K-86.1% | 5.78M | |
| Other non-operating income | -806K+76.9% | -3.48M-130.1% | -1.51M | |
| Pre-tax income | -12.8M+72.9% | -47.1M+30.2% | -67.5M | |
| Income tax | 0.00 | 0.00 | 0.00 | |
| Net income | -12.8M+72.9% | -47.1M+30.2% | -67.5M | |
| -$0.35+94.3% | -$6.11+35.8% | -$9.52 | ||
| EPS (basic) | -$0.35+94.3% | -$6.11+35.8% | -$9.52 | |
| Weighted-avg shares (basic) | 36.6M+374.5% | 7.72M+8.9% | 7.09M | |
| Weighted-avg shares (diluted) | 36.6M+374.5% | 7.72M+8.9% | 7.09M | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | |
| 273M+141.4% | 113M | — | ||
| Cash & equivalents | 222M+190.7% | 76.4M-33.9% | 116M | |
| Accounts receivable | 34.6M+47.7% | 23.4M | — | |
| Inventory | 4.49M+36.1% | 3.30M | — | |
| Prepaid expenses | 8.29M+19.5% | 6.94M | — | |
| Other current assets | 1.89M-11.7% | 2.14M | — | |
| 305M+102.4% | 151M | — | ||
| Property, plant & equipment | 7.94M+41.2% | 5.63M | — | |
| Operating lease right-of-use | 0.00-100.0% | 447K | — | |
| Goodwill | 13.2M+0.0% | 13.2M | — | |
| Intangible assets | 2.41M-43.4% | 4.26M | — | |
| Other non-current assets | 165K-96.7% | 5.04M | — | |
| 75.7M+40.4% | 54.0M | — | ||
| Accounts payable | 10.3M+146.5% | 4.17M | — | |
| Accrued liabilities | 40.4M+35.4% | 29.8M | — | |
| Deferred revenue | 25.1M+28.3% | 19.5M | — | |
| Current lease liability | 0.00-100.0% | 415K | — | |
| 75.7M-12.2% | 86.3M | — | ||
| Long-term debt | 0.00-100.0% | 29.8M | — | |
| Other non-current liabilities | 0.00-100.0% | 285K | — | |
| 230M+159.7% | -384M-9.8% | -350M | ||
| Common stock | 58.0K+625.0% | 8.00K | — | |
| Additional paid-in capital | 686M+1052.5% | 59.6M | — | |
| Retained earnings | -457M-2.9% | -444M | — | |
| Total liabilities & equity | 305M+102.4% | 151M | — | |
| Common shares issued | 58.4M+616.3% | 8.16M | — | |
| Common shares outstanding | 58.4M+616.3% | 8.16M | — | |
| Shares outstanding (cover) | 58.9M | — | — | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | |
| 18.3M+153.4% | -34.2M+31.3% | -49.7M | ||
| Depreciation & amortization | 5.49M+14.3% | 4.80M+8.0% | 4.45M | |
| Intangible amortization | 1.90M-5.0% | 2.00M+0.0% | 2.00M | |
| Share-based compensation | 13.0M+37.5% | 9.42M+7.8% | 8.74M | |
| Change in receivables | 12.4M+40.3% | 8.80M+65.0% | 5.34M | |
| Change in inventory | 1.19M+474.2% | -318K-529.7% | 74.0K | |
| Change in payables | 6.29M+1476.2% | 399K+239.5% | -286K | |
| -5.83M-51.0% | -3.86M-32.2% | -2.92M | ||
| Capital expenditure | 1.32M+121.8% | 596K+43.3% | 416K | |
| Free cash flow | 16.9M+148.7% | -34.8M+30.7% | -50.2M | |
| Acquisitions | 0.00 | 0.00 | 0.00 | |
| 133M+11119.4% | -1.21M-775.4% | 179K | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | |
| Net change in cash | 146M+471.1% | -39.3M+25.2% | -52.5M | |
| Interest paid | 2.42M-37.2% | 3.85M-5.9% | 4.09M | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | |
| Market cap | 930M | — | — | |
| P/S | 3.6× | — | — | |
| P/B | 4.0× | — | — | |
| P/FCF | 54.9× | — | — | |
| FCF yield | 1.8% | — | — | |
| Source filing | 10-K | 10-K | 10-K |
About this data
Source: OMDA’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all OMDA filings on SEC EDGAR → Not investment advice.